| Year |
Title |
Altmetric |
| 2019
|
Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway.
Frontiers in Immunology.
10.
2019
|
|
| 2019
|
Primary HIV-1 strains use nef to downmodulate HLA-E surface expression.
Journal of Virology.
93.
2019
|
|
| 2019
|
Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model.
Science Translational Medicine.
11.
2019
|
|
| 2019
|
Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).
Molecular and Cellular Endocrinology.
492.
2019
|
|
| 2019
|
Accumulated mutations by 6 months of infection collectively render transmitted/founder HIV-1 significantly less fit.
Journal of Infection.
2019
|
|
| 2019
|
Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction.
PLoS ONE.
14.
2019
|
|
| 2018
|
Incomplete downregulation of CD4 expression affects HIV-1 Env conformation and antibody-dependent cellular cytotoxicity responses..
Journal of Virology.
92.
2018
|
|
| 2018
|
Structural stability of purified human CFTR is systematically improved by mutations in nucleotide binding domain 1.
BBA - Biomembranes.
1860:1193-1204.
2018
|
|
| 2017
|
Potent in vivo NK cellmediated elimination of HIV-1-infected cells mobilized by a gp120-bispecific and hexavalent broadly neutralizing fusion protein.
Journal of Virology.
91.
2017
|
|
| 2017
|
Glycosylation benchmark profile for HIV-1 envelope glycoprotein production based on eleven Env trimers.
Journal of Virology.
91.
2017
|
|
| 2017
|
Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies.
Science Translational Medicine.
9.
2017
|
|
| 2017
|
Dendritic cells from the human female reproductive tract rapidly capture and respond to HIV.
Mucosal Immunology.
10:531-544.
2017
|
|
| 2017
|
Evaluation of the contribution of the transmembrane region to the ectodomain conformation of the human immunodeficiency virus (HIV-1) envelope glycoprotein.
Virology Journal.
14.
2017
|
|
| 2017
|
Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs.
PLoS ONE.
12.
2017
|
|
| 2017
|
Specific stabilization of CFTR by phosphatidylserine.
BBA - Biomembranes.
1859:289-293.
2017
|
|
| 2017
|
The transcriptome of HIV-1 infected intestinal CD4+ T cells exposed to enteric bacteria.
PLoS Pathogens.
13.
2017
|
|
| 2017
|
Substitution of Yor1p NBD1 residues improves the thermal stability of human cystic fibrosis transmembrane conductance regulator.
Protein Engineering -Oxford-.
30:729-741.
2017
|
|
| 2017
|
The cystic fibrosis transmembrane conductance regulator potentiator ivacaftor augments mucociliary clearance abrogating cystic fibrosis transmembrane conductance regulator inhibition by cigarette smoke.
American Journal of Respiratory Cell and Molecular Biology.
56:99-108.
2017
|
|
| 2016
|
Diversity of antiviral IgG effector activities observed in HIV-infected and vaccinated subjects.
Journal of Immunology.
197:4603-4612.
2016
|
|
| 2016
|
Expression and purification of the alpha subunit of the epithelial sodium channel, ENaC.
Protein Expression and Purification.
117:67-75.
2016
|
|
| 2016
|
Fisetin, a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma.
Oncotarget.
7:1227-1241.
2016
|
|
| 2016
|
High-throughput humanized mouse models for evaluation of HIV-1 therapeutics and pathogenesis.
Methods in Molecular Biology.
1354:221-235.
2016
|
|
| 2016
|
Inhibition of NADPH oxidase 1 activity and blocking the binding of cytosolic and membrane-bound proteins by honokiol inhibit migratory potential of melanoma cells.
Oncotarget.
7:7899-7912.
2016
|
|
| 2015
|
Optimized Replicating Renilla Luciferase Reporter HIV-1 Utilizing Novel Internal Ribosome Entry Site Elements for Native Nef Expression and Function.
AIDS Research and Human Retroviruses.
31:1278-1296.
2015
|
|
| 2015
|
A Stable Human-Cell System Overexpressing Cystic Fibrosis Transmembrane Conductance Regulator Recombinant Protein at the Cell Surface.
Molecular Biotechnology.
57:391-405.
2015
|
|
| 2015
|
Erratum to: A Stable Human-Cell System Overexpressing Cystic Fibrosis Transmembrane Conductance Regulator Recombinant Protein at the Cell Surface [Mol Biotechnol, DOI 10.1007/s12033-014-9830-5].
Molecular Biotechnology.
57:406.
2015
|
|
| 2015
|
Comparative analysis of the glycosylation profiles of membrane-anchored HIV-1 envelope glycoprotein trimers and soluble gp140.
Journal of Virology.
89:8245-8257.
2015
|
|
| 2015
|
In vivo activation of human NK cells by treatment with an interleukin-15 superagonist potently inhibits acute in vivo HIV-1 infection in humanized mice.
Journal of Virology.
89:6264-6274.
2015
|
|
| 2015
|
The vaginal acquisition and dissemination of HIV-1 infection in a novel transgenic mouse model is facilitated by coinfection with herpes simplex virus 2 and is inhibited by microbicide treatment.
Journal of Virology.
89:9559-9570.
2015
|
|
| 2015
|
Therapeutic intervention of proanthocyanidins on the migration capacity of melanoma cells is mediated through PGE2 receptors and β-catenin signaling molecules.
American Journal of Cancer Research.
5:3325-3338.
2015
|
|
| 2014
|
Macrophage infection via selective capture of HIV-1-infected CD4+ T cells.
Cell Host and Microbe.
16:711-721.
2014
|
|
| 2014
|
Global panel of HIV-1 env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies.
Journal of Virology.
88:2489-2507.
2014
|
|
| 2014
|
High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse.
Journal of Virology.
88:2025-2034.
2014
|
|
| 2014
|
Erratum: Resveratrol Enhances Airway Surface Liquid Depth in Sinonasal Epithelium by Increasing Cystic Fibrosis Transmembrane Conductance Regulator Open Probability (PLoS ONE (2014) 9:1 (DOI:10.1371/annotation/d852ff1d-2824- 4f4d-80f2-9be7a42a5f25)).
PLoS ONE.
9.
2014
|
|
| 2014
|
A survey of detergents for the purification of stable, active human cystic fibrosis transmembrane conductance regulator (CFTR).
BBA - Biomembranes.
1838:2825-2837.
2014
|
|
| 2014
|
Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation.
Journal of Cell Biology.
206:867-876.
2014
|
|
| 2014
|
Correction to Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation [Journal of Cell Biology, 206, 7, (2014), 867-876].
Journal of Cell Biology.
207:159.
2014
|
|
| 2014
|
Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses.
Journal of Immunological Methods.
409:161-173.
2014
|
|
| 2014
|
Membrane protein stability can be compromised by detergent interactions with the extramembranous soluble domains.
Protein Science.
23:769-789.
2014
|
|
| 2014
|
Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells.
Journal of Immunological Methods.
409:147-160.
2014
|
|
| 2014
|
Vaginal myeloid dendritic cells transmit founder HIV-1.
Journal of Virology.
88:7683-7688.
2014
|
|
| 2013
|
Relative resistance of HIV-1 founder viruses to control by interferon-alpha.
Retrovirology.
10.
2013
|
|
| 2013
|
Impact of HIV-1 backbone on neutralization sensitivity: Neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01-AE backbone.
PLoS ONE.
8.
2013
|
|
| 2013
|
Detection of HIV-1 neutralizing antibodies in a human CD4 +/CXCR4+/CCR5+ T-lymphoblastoid cell assay system.
PLoS ONE.
8.
2013
|
|
| 2013
|
Resveratrol enhances airway surface liquid depth in sinonasal epithelium by increasing cystic fibrosis transmembrane conductance regulator open probability.
PLoS ONE.
8.
2013
|
|
| 2013
|
The silent codon change I507-ATC→ATT contributes to the severity of the AF508 CFTR channel dysfunction.
Federation proceedings.
27:4630-4645.
2013
|
|
| 2013
|
Lyn Facilitates Glioblastoma Cell Survival under Conditions of Nutrient Deprivation by Promoting Autophagy.
PLoS ONE.
8.
2013
|
|
| 2013
|
Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees.
Journal of Virology.
87:7828-7836.
2013
|
|
| 2013
|
Mice Transgenic for CD4-Specific Human CD4, CCR5 and Cyclin T1 Expression: A New Model for Investigating HIV-1 Transmission and Treatment Efficacy.
PLoS ONE.
8.
2013
|
|
| 2013
|
Phenotypic properties of transmitted founder HIV-1.
Proceedings of the National Academy of Sciences.
110:6626-6633.
2013
|
|
| 2013
|
L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor.
Clinical and Experimental Metastasis.
30:507-520.
2013
|
|
| 2013
|
Optimization of the transductional efficiency of lentiviral vectors: Effect of sera and polycations.
Molecular Biotechnology.
53:308-314.
2013
|
|
| 2013
|
Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones.
Virology.
436:33-48.
2013
|
|
| 2013
|
Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virus.
Journal of Virology.
87:890-899.
2013
|
|
| 2012
|
HIV-1 Expressing the Envelopes of Transmitted/Founder or Control/Reference Viruses Have Similar Infection Patterns of CD4 T-Cells in Human Cervical Tissue Ex Vivo.
PLoS ONE.
7.
2012
|
|
| 2012
|
Short communication: HIV type 1 escapes inactivation by saliva via rapid escape into oral epithelial cells.
AIDS Research and Human Retroviruses.
28:1574-1578.
2012
|
|
| 2012
|
A young hispanic with c.1646G>A mutation exhibits severe cystic fibrosis lung disease: Is ivacaftor an option for therapy?.
American Journal of Respiratory and Critical Care Medicine.
186:694-696.
2012
|
|
| 2012
|
Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.
Journal of Virology.
86:9055-9069.
2012
|
|
| 2012
|
Antibody-dependent cellular cytotoxicity against primary hivinfected CD4 + T cells is directly associated with the magnitude of surface igg binding.
Journal of Virology.
86:8672-8680.
2012
|
|
| 2012
|
Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials.
Journal of Infectious Diseases.
206:431-441.
2012
|
|
| 2012
|
Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication.
Journal of Virology.
86:6835-6846.
2012
|
|
| 2012
|
Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract.
PLoS ONE.
7.
2012
|
|
| 2012
|
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7.
PLoS Pathogens.
8.
2012
|
|
| 2012
|
The role of natural killer (NK) cells and nk cell receptor polymorphisms in the assessment of HIV-1 neutralization.
PLoS ONE.
7.
2012
|
|
| 2012
|
Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages.
Journal of Virology.
86:2715-2728.
2012
|
|
| 2012
|
Purification of CFTR for mass spectrometry analysis: Identification of palmitoylation and other post-translational modifications.
Protein Engineering -Oxford-.
25:7-14.
2012
|
|
| 2011
|
IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation.
AIDS.
25:2099-2104.
2011
|
|
| 2011
|
Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection.
Journal of Virology.
85:11196-11207.
2011
|
|
| 2011
|
L1 stimulation of human glioma cell motility correlates with FAK activation.
Journal of Neuro-Oncology.
105:27-44.
2011
|
|
| 2011
|
High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses.
Cytometry Part A.
79 A:603-612.
2011
|
|
| 2011
|
An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum.
Journal of Virology.
85:7029-7036.
2011
|
|
| 2011
|
Stromal down-regulation of macrophage CD4/CCR5 expression and NF-κB activation mediates HIV-1 non-permissiveness in intestinal macrophages.
PLoS Pathogens.
7.
2011
|
|
| 2011
|
Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner.
Neuro-Oncology.
13:28-41.
2011
|
|
| 2010
|
Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC.
Virology.
408:1-13.
2010
|
|
| 2010
|
Uterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cells.
PLoS ONE.
5.
2010
|
|
| 2010
|
A synonymous single nucleotide polymorphism in ΔF508 CFTR alters the secondary structure of the mRNA and the expression of the mutant protein.
Journal of Biological Chemistry.
285:28741-28748.
2010
|
|
| 2010
|
Anti-HIV activity in cervical-vaginal secretions from HIV-Positive and -Negative women correlate with innate antimicrobial levels and IgG antibodies.
PLoS ONE.
5.
2010
|
|
| 2010
|
Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination.
Journal of Virology.
84:4998-5006.
2010
|
|
| 2010
|
Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines.
Journal of Experimental Medicine.
207:763-776.
2010
|
|
| 2010
|
GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium.
Journal of Immunology.
184:3648-3655.
2010
|
|
| 2010
|
Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection.
European Journal of Immunology.
40:949-954.
2010
|
|
| 2010
|
Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production.
AIDS Research and Human Retroviruses.
26:279-291.
2010
|
|
| 2009
|
Cystin localizes to primary cilia via membrane microdomains and a targeting motif.
Journal of the American Society of Nephrology.
20:2570-2580.
2009
|
|
| 2009
|
Tetherin-Driven Adaptation of Vpu and Nef Function and the Evolution of Pandemic and Nonpandemic HIV-1 Strains.
Cell Host and Microbe.
6:409-421.
2009
|
|
| 2009
|
P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays.
Retrovirology.
6.
2009
|
|
| 2009
|
P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific.
Retrovirology.
6.
2009
|
|
| 2009
|
P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.
Retrovirology.
6.
2009
|
|
| 2009
|
P20-15. Evaluation of HIV-1 subtype B acute envelope-expressing infectious molecular clones.
Retrovirology.
6.
2009
|
|
| 2009
|
S01-04 OA. Phenotypic analyses of CD8+ T cells that mediate virus inhibition from HIV-1 vaccinees and HIV-1+ virus controllers.
Retrovirology.
6.
2009
|
|
| 2009
|
Clinical and molecular characterization of S1118F-CFTR.
Pediatric Pulmonology.
44:1003-1009.
2009
|
|
| 2009
|
New virologic reagents for neutralizing antibody assays.
Current Opinion in HIV and AIDS.
4:418-425.
2009
|
|
| 2009
|
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.
Journal of Experimental Medicine.
206:1273-1289.
2009
|
|
| 2009
|
COP9-associated CSN5 regulates exosomal protein deubiquitination and sorting.
American Journal of Pathology.
174:1415-1425.
2009
|
|
| 2009
|
Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes..
AIDS.
23:2069-2077.
2009
|
|
| 2008
|
Calmodulin binding to cellular FLICE-like inhibitory protein modulates Fas-induced signalling.
Biochemical Journal.
412:459-468.
2008
|
|
| 2008
|
Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling.
Journal of Biological Chemistry.
283:15319-15327.
2008
|
|
| 2007
|
Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.
AIDS.
21:2387-2397.
2007
|
|
| 2007
|
Neural progenitor cell transplantation and imaging in a large animal model.
Neuroscience Research.
59:327-340.
2007
|
|
| 2007
|
HIV-1 Protease Dimer Interface Mutations that Compensate for Viral Reverse Transcriptase Instability in Infectious Virions.
Journal of Molecular Biology.
372:369-381.
2007
|
|
| 2007
|
Breast cancer metastasis to bone: Evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice.
Clinical and Experimental Metastasis.
24:389-401.
2007
|
|
| 2007
|
Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
Journal of Virology.
81:7238-7248.
2007
|
|
| 2007
|
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host.
Blood.
109:4336-4342.
2007
|
|
| 2007
|
Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy.
JNCI: Journal of the National Cancer Institute.
99:309-321.
2007
|
|
| 2007
|
Analysis of Amino Acids in the β7-β8 Loop of Human Immunodeficiency Virus Type 1 Reverse Transcriptase for their Role in Virus Replication.
Journal of Molecular Biology.
365:1368-1378.
2007
|
|
| 2006
|
Tethering KSRP, a decay-promoting AU-rich element-binding protein, to mRNAs elicits mRNA decay.
Molecular and Cellular Biology.
26:3695-3706.
2006
|
|
| 2006
|
Kinetics of metastatic breast cancer cell trafficking in bone.
Clinical Cancer Research.
12:1431-1440.
2006
|
|
| 2006
|
Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function.
Journal of Immunology.
176:1375-1385.
2006
|
|
| 2005
|
Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells.
Antimicrobial Agents and Chemotherapy.
49:3762-3769.
2005
|
|
| 2005
|
Identification of amino acid residues in the human immunodeficiency virus type-1 reverse transcriptase tryptophan-repeat motif that are required for subunit interaction using infectious virions.
Journal of Molecular Biology.
349:673-684.
2005
|
|
| 2004
|
Clonal selection for transcriptionally active viral oncogenes during progression to cancer.
Journal of Virology.
78:11172-11186.
2004
|
|
| 2004
|
Evidence that stable retroviral transduction and cell survival following DNA integration depend on components of the nonhomologous end joining repair pathway.
Journal of Virology.
78:8573-8581.
2004
|
|
| 2004
|
Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.
Journal of Virology.
78:7089-7096.
2004
|
|
| 2003
|
Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): Naturally selected mutations in IN augment DNA synthesis.
Journal of Virology.
77:11050-11059.
2003
|
|
| 2003
|
Erratum: Antibody neutralization and escape by HIV-1 (Nature (2003) 422 (307-312)).
Nature.
423:197.
2003
|
|
| 2003
|
Antibody neutralization and escape by HIV-1.
Nature.
422:307-312.
2003
|
|
| 2003
|
Production of trans-lentiviral vector with predictable safety..
Methods in Molecular Medicine.
76:449-465.
2003
|
|
| 2002
|
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.
Antimicrobial Agents and Chemotherapy.
46:1896-1905.
2002
|
|
| 2002
|
The promoter of the human proliferating cell nuclear antigen gene is not sufficient for cell cycle-dependent regulation in organotypic cultures of keratinocytes.
Journal of Biological Chemistry.
277:17271-17280.
2002
|
|
| 2002
|
The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.
Journal of Virology.
76:4331-4340.
2002
|
|
| 2002
|
Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells.
Nature Medicine.
8:150-156.
2002
|
|
| 2001
|
Moloney murine leukemia virus integrase protein augments viral DNA synthesis in infected cells.
Journal of Virology.
75:11365-11372.
2001
|
|
| 2001
|
Safety considerations in vector development.
Somatic Cell and Molecular Genetics.
26:147-158.
2001
|
|
| 2001
|
Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1.
Nature Medicine.
7:920-926.
2001
|
|
| 2001
|
Analysis of lenti- and trans-lentiviral vector genetic recombination..
Developments in Biological Standardization.
106.
2001
|
|
| 2000
|
Analysis of human immunodeficiency virus type 1 containing HERV-K protease.
AIDS Research and Human Retroviruses.
16:1973-1980.
2000
|
|
| 2000
|
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.
Journal of Virology.
74:8358-8367.
2000
|
|
| 2000
|
Development of a novel trans-lentiviral vector that affords predictable safety.
Molecular Therapy.
2:47-55.
2000
|
|
| 2000
|
Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice.
STEM CELLS.
18:352-359.
2000
|
|
| 1999
|
Targeting human immunodeficiency virus (HIV) type 2 integrase protein into HIV type 1.
Journal of Virology.
73:8831-8836.
1999
|
|
| 1999
|
Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex.
Journal of Virology.
73:2126-2135.
1999
|
|
| 1998
|
The cysteine-cysteine family of chemokines RANTES, MIP-1α, and MIP-1β induce trypanocidal activity in human macrophages via nitric oxide.
Infection and Immunity.
66:4690-4695.
1998
|
|
| 1997
|
Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
Journal of Virology.
71:7704-7710.
1997
|
|
| 1997
|
Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
EMBO Journal.
16:5113-5122.
1997
|
|
| 1996
|
Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.
Journal of Virology.
70:3378-3384.
1996
|
|
| 1996
|
Proteolytic activity of human immunodeficiency virus Vpr-and Vpx-protease fusion proteins.
Virology.
219:307-313.
1996
|
|
| 1995
|
Assessment of antiretroviral therapy by plasma viral load testing: Standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology.
10:139-149.
1995
|
|
| 1995
|
Polyclonal Rabbit Antisera that Detect the Vpr Protein of SIVSM and SIVMAC on Immunoblots of Purified Virions.
AIDS Research and Human Retroviruses.
11:405-408.
1995
|
|
| 1995
|
Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.
Journal of Virology.
69:3389-3398.
1995
|
|
| 1995
|
The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
Journal of Virology.
69:7630-7638.
1995
|
|
| 1995
|
Viral protein X.
Current Topics in Microbiology and Immunology.
193:121-132.
1995
|
|
| 1994
|
Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.
Journal of Virology.
68:6161-6169.
1994
|
|
| 1994
|
Optimization of quantitative culture assay for human immunodeficiency virus from plasma.
Journal of Clinical Microbiology.
32:3064-3067.
1994
|
|
| 1993
|
Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.
AIDS.
7.
1993
|
|
| 1993
|
A Short-Term Clinical Evaluation of L-697,661, a Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase.
New England Journal of Medicine.
329:1065-1072.
1993
|
|
| 1993
|
Viral dynamics in primary HIV-1 infection.
Lancet.
341:1099.
1993
|
|
| 1993
|
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.
Science.
259:1749-1754.
1993
|
|
| 1993
|
Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components.
Virology.
193:222-233.
1993
|
|
| 1993
|
Viral dynamics in primary HIV-1 infection [21].
Lancet.
341:1099.
1993
|
|
| 1991
|
High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.
New England Journal of Medicine.
324:954-960.
1991
|
|
| 1991
|
Human immunodeficiency virus type 2 vpx protein augments viral infectivity.
Virology.
184:197-209.
1991
|
|
| 1991
|
Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes.
Journal of Virology.
65:3973-3985.
1991
|
|
| 1990
|
Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate.
Journal of Virology.
64:890-901.
1990
|
|
| 1988
|
Enhanced in vitro reactivation of latent herpes simplex virus from neural and peripheral tissues with hexamethylenebisacetamide.
Archives of Virology.
99:57-65.
1988
|
|
| 1988
|
Antibody to herpes simplex virus (Hsv) icp-35 proteins after hsv challenge of animals immunized with hsv subunit vaccines.
Journal of Infectious Diseases.
157:1178-1186.
1988
|
|
| 1988
|
Enhanced in vitro reactivation of herpes simplex virus type 2 from latency infected guinea-pig neural tissues by 5-azacytidine.
Journal of General Virology.
69:1079-1083.
1988
|
|
| 1988
|
Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIV(MAC).
Journal of Virology.
62:3501-3505.
1988
|
|
| 1988
|
West African HIV-2-related human retrovirus with attenuated cytopathicity.
Science.
240:1525-1529.
1988
|
|
| 1987
|
Antibody Response to Herpes Simplex Virus Glycoprotein d: Effects of Acyclovir and Relation to Recurrence.
Journal of Infectious Diseases.
156:423-429.
1987
|
|
| 1986
|
Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: Effects of acyclovir.
Journal of General Virology.
67:1601-1612.
1986
|
|
